Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Special Drug Use Investigation for AMERGE® Tablet (Long-term)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline
ClinicalTrials.gov Identifier:
NCT01332383
First received: April 7, 2011
Last updated: August 10, 2015
Last verified: August 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2013
  Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)